ACV's $10.50 cash offer leaves less than 1% spread, not a 10/5 long

Summary: Copart agreed to acquire ACV Auctions for $10.50 per share in cash, subject to a tender offer, majority tender condition, HSR expiration, and other customary conditions. ACV's latest reference was $10.41 after a 44% event jump. The gross spread is less than 1%, while a deal break can return the stock to a materially lower standalone value. This is a merger-research screen, not an executable long. The paired signal is watch, with entry.price: null and execution.can_execute: false.

Opportunity Ranking

Rank	Candidate	Direction	Mispricing	Evidence Freshness	Catalyst Window	Positioning	10/5 Status	Tradeability	Main Rejection Risk
1	ACV Auctions (ACVA)	Long	Cash offer versus a sub-1% spread	Sep. 10 merger filing and Sep. 11 tape	Tender, HSR and close	Direct positioning unavailable; event tape observable	Reject: base +0.86%, adverse -27.9%, negative ratio	Liquid event tape, but exit audit missing	Deal break, tender, regulation
2	Lattice Semiconductor (LSCC)	Long	AMI run-rate versus 460× P/E	Jul.-Aug. primary results	Q3 integration	Positioning unavailable	Reject	Liquid, prior screen	Valuation, integration
3	GoPro (GPRO)	Long	Recap cash and retained stake versus private optical risk	Sep. 1 merger filing	Vote and close	Positioning unavailable	Reject	Thin, prior screen	Closing, dilution

Selected opportunity: ACV Auctions, for research only.

Why this one now: It is a distinct target-side view of the Copart transaction. The merger agreement is clear, the offer is cash, and the current spread can be calculated exactly. The calculation demonstrates why a completed announcement is not equivalent to a low-risk long.

What should surprise the reader: The offer premium is measured from August 10, before media reports. A buyer today receives less than 1% gross upside while still carrying the full deal-break downside.

Why This Is the Best Opportunity Right Now

Copart will commence a tender offer for all ACV shares at $10.50 cash. The offer requires at least a majority of shares tendered, HSR expiration, and other customary conditions. Closing is expected by calendar year-end 2026, and the offer has no financing condition. ACV merger filing

Why This Can Move More Than 5% Soon

The catalysts are offer launch, tender participation, HSR clearance, litigation or competing bids, and closing. The latest reference was $10.41 at 2026-09-11T23:36:21Z after trading $10.32-$10.46 on 115.5 million shares. ACVA market reference

10/5 Asymmetry Gate

The map uses the $10.41 reference. The top case is $10.50, the contractual cash consideration. The base is also $10.50 because no superior bid is evidenced. The bottom is $7.50, a conservative standalone break level after a failed transaction and loss of takeover momentum.

Input	Result
Base move to $10.50	+0.86%
Credible adverse move to $7.50	-27.95%
Gross reward / adverse risk	0.03:1
Probability-weighted expected move	-6.19%
10/5 status	Reject

The spread is immaterial, expected value is negative, and the break case is far above 5%.

What Should Surprise the Reader

The all-cash offer removes financing-condition risk but does not remove tender, regulatory, litigation, or timing risk. The market is already valuing most of the contractual consideration; what remains is a narrow spread with a fat downside tail.

The Setup

ACV operates a digital dealer-to-dealer marketplace, while Copart contributes physical locations, buyer reach, and salvage-market infrastructure. ACV holders have a binary path: tender and receive cash if conditions clear, or retain a standalone business if the deal fails. The long case is therefore event-driven, not a normal operating-growth thesis.

The Market Price

The latest reference was $10.41 at 2026-09-11T23:36:21Z. The feed reported $10.32-$10.46 and 115,502,857 shares. Spread, depth, venue quality, settlement, and exit liquidity were not verified.

The Mispricing

The market may underprice the probability that Copart closes the transaction cleanly. The counterview is that the 0.86% gross spread cannot compensate for a break, delay, or litigation path. This is a probability-and-time-value screen, not a cheap-stock thesis.

The Positioning

Direct current positioning, borrow terms, and dealer exposure were not reliably available. The very large event volume is observable but cannot prove the spread is safe. Positioning confidence is low.

The Catalyst

Tender launch: verify Schedule TO, offer terms, majority tender condition, and any extensions.
Regulatory path: verify HSR expiry, litigation, and other closing conditions.
Closing or break: verify cash settlement by year-end 2026 or a break that resets ACV's standalone value.

The cheapest falsification is any filing showing delayed offer launch, unusual tender conditions, litigation, or regulatory objections. Those observations eliminate the sub-1% spread immediately.

The Payoff

The top and base cases both pay $10.50. The bottom case is a standalone ACV market with takeover premium removed. There is no evidence supporting a superior bid, so a $10.50 cash offer is the only responsible upside anchor.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Horizon	Conditions	Evidence Quality
Top Case	25%	$10.50	+0.86%	Through close	Offer launches and closes cleanly	High
Base Case	50%	$10.50	+0.86%	Through close	Conditions satisfied, no superior bid	High
Bottom Case	25%	$7.50	-27.95%	Same window	Deal breaks or is materially delayed	Medium
Invalidation	n/a	Offer fails	Thesis invalidated	Before close	Tender, HSR, litigation or other condition fails	High

Probability-weighted expected value: $9.765, or -6.19% before costs.

Current market level and timestamp: $10.41 after-hours reference at 2026-09-11T23:36:21Z.

Primary instrument: ACVA common stock only, unlevered.

10/5 favorable base move: +0.86% from the reference, not an executable entry.

10/5 credible adverse move: -27.95% from the reference.

10/5 measurement basis: reference-only.

10/5 status: Reject.

Confidence: Medium. Offer terms are primary and clear, but tender, regulatory, litigation, and settlement evidence are incomplete.

The Kill Shot

The strongest counterparty view is that no financing condition and unanimous board approval make closing highly probable. The load-bearing assumption is still timing and condition satisfaction. A 0.86% gross spread cannot survive even a small probability of a break or a long settlement delay.

What Could Go Wrong

The tender may not reach the majority threshold; HSR or other approvals can delay or block it; stockholder litigation can add cost; a competing bid can complicate terms; and the standalone business may be worth substantially less without takeover momentum. Gaps, halts, slippage, and settlement risk matter in a thin event-driven instrument.

What Would Prove This Wrong

The screen remains invalid as an attractive long if the offer closes only after an extended delay, if settlement terms change, or if ACV trades above $10.50 without a superior bid. The current spread cannot be widened by narrative alone.

Risk Audit

Evidence: merger agreement and SEC exhibit are primary; tender materials are not yet filed.
Spread: less than 1% gross before fees, time, and execution costs.
Break: standalone price risk dominates the small contractual upside.
Positioning: direct current positioning unavailable.
Execution: entry.price remains null and execution is blocked. No options, leverage, margin, market order, or price-floor expression is supported.

Best Trade Strategy

There is no trade-qualified strategy in this run. Keep ACVA on a research watch only. Re-open after the Schedule TO, HSR status, tender participation, and settlement mechanics are observable. Do not treat the cash offer as a guaranteed floor.

Sources

Copart-ACV merger Exhibit 99.1, September 10, 2026.
ACVA market reference, observed September 11, 2026 at 23:36:21Z.
Copart investor relations, transaction and Q4 disclosures.
Lattice AMI completion, July 27, 2026.
Chime Stride agreement, September 8, 2026.

Research Quality Scorecard

Criterion	Score	Reason
Market disagreement	5/5	Contractual cash, spread, and break risk are explicit
Evidence base	5/5	Fresh SEC transaction exhibit and market reference
Positioning and flows	2/5	Direct positioning unavailable; event tape is only a clue
Catalyst path	5/5	Tender, HSR, litigation, settlement, and close are observable
Payoff architecture	4/5	Contractual target and break case are explicit
Invalidation discipline	5/5	Offer-condition tests are monitorable
Differentiated insight	5/5	Small spread cannot compensate for binary break risk
Client value	4/5	Shows exactly why merger-arbitrage language is not a long command

Total: 35/40. Publishable research quality, but the 10/5 and ratio failures force Reject/no-trade classification.

Bottom Line

ACV's cash offer is clear at $10.50, but the current $10.41 reference leaves less than 1% upside against a credible standalone break far below $10. The expected move is -6.19% and gross reward to adverse risk is 0.03:1. The correct output is one substantive no-trade long screen, not an invented entry.

AI Illustration Prompt

Editorial financial illustration: two digital vehicle auction lanes converging at a cash offer ticket marked “$10.50,” with a narrow green spread and a large red break-risk drop beneath; auction inspection screens, merger documents, and tender envelopes; steel blue, cream, orange, and warning red palette; documentary realism, clean negative space, no trading interface, no price prediction; add a subtle readable “The Mispricing Desk” watermark in the lower-right corner.